TRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease

NCT03539380 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: TRx0237

Sponsor

TauRx Therapeutics Ltd